In an interview, outgoing CDC Director Mandy Cohen defended the agency’s wide focus in the face of GOP criticism that it has ...

Health care did not play a big role in the election that’s sending President Trump back to the White House and giving ...

The new administration wants “a break” from infectious disease research to focus on chronic disease. That’s impossible, ...

State officials failed to discipline Steward for regulatory violations, check its expansion plans and cost-cutting, or ...

In this week’s letters to the editor, STAT readers weigh in on the health care system, pediatrics, and mental-health apps.

The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.

A health insurance company executive turned whistleblower, Wendell Potter thinks that the backlash to the industry is missing ...

After public health labs in California failed to confirm a positive result, a sample was sent to the CDC, which Thursday said ...

"Patients will die as a result of this decision," said Gayle Pledger of the Right to Breathe advocacy campaign.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Today's health news in STAT Morning Rounds includes HHMI's new eligibility criteria, the latest on a California bird flu ...

Most patients with chronic lymphocytic leukemia eventually relapse. A bispecific antibody drug may give them "another can to ...